U.S. Markets closed

Here's Another Checkmark For Bristol's Looming Celgene Takeover

ALLISON GATLIN
Here's Another Checkmark For Bristol's Looming Celgene Takeover

Shares of biotech company Celgene rose Tuesday after the FDA accepted its application for an Acceleron Pharma-partnered anemia treatment in beta thalassemia and some blood cancers.